Viewing Study NCT06950034


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-27 @ 10:58 PM
Study NCT ID: NCT06950034
Status: RECRUITING
Last Update Posted: 2025-04-29
First Post: 2025-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Sponsor: Solu Therapeutics, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module